Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
87.84
-5.20 (-5.59%)
At close: Mar 5, 2026, 4:00 PM EST
88.01
+0.17 (0.19%)
After-hours: Mar 5, 2026, 7:17 PM EST
Mirum Pharmaceuticals Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for Mirum Pharmaceuticals stock have an average target of 114.67, with a low estimate of 77 and a high estimate of 132. The average target predicts an increase of 30.54% from the current stock price of 87.84.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Mirum Pharmaceuticals stock from 12 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 5 | 5 | 5 | 4 |
| Buy | 6 | 6 | 6 | 6 | 8 | 8 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 11 | 11 | 13 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $101 → $126 | Buy | Maintains | $101 → $126 | +43.44% | Mar 4, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $120 → $118 | Buy | Maintains | $120 → $118 | +34.34% | Feb 26, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $115 → $117 | Strong Buy | Maintains | $115 → $117 | +33.20% | Feb 26, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $130 → $128 | Buy | Maintains | $130 → $128 | +45.72% | Feb 26, 2026 |
| Citizens | Citizens | Buy Maintains $140 → $132 | Buy | Maintains | $140 → $132 | +50.27% | Feb 26, 2026 |
Financial Forecast
Revenue This Year
649.60M
from 521.31M
Increased by 24.61%
Revenue Next Year
790.92M
from 649.60M
Increased by 21.75%
EPS This Year
-0.97
from -0.47
EPS Next Year
0.16
from -0.97
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 686.0M | 883.9M | |||
| Avg | 649.6M | 790.9M | |||
| Low | 567.4M | 695.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 31.6% | 36.1% | |||
| Avg | 24.6% | 21.8% | |||
| Low | 8.8% | 7.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 0.68 | 2.10 | |||
| Avg | -0.97 | 0.16 | |||
| Low | -2.52 | -1.60 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.